No description available.

No description available.

No description available.

Chronic pain has an adverse impact on the quality of life in children and adolescents. It can impair a child’s physical, psychological, and social functioning, leading to lower satisfaction with life and poor self-image related to health status. Forty-five percent of children experience chronic pain related to either disease processes or idiopathic causes. Not all children who suffer from chronic pain respond to traditional therapies. The purpose of this literature review was evaluation of current research on the use of yoga as an integrative therapy for chronic pain management in the pediatric population. A database search of CINAHL, MEDLINE, and PsycINFO was conducted. Yoga has few side effects, is inexpensive, and can be practiced almost anywhere, regardless of physical ability or age. There is limited research on the use of yoga as an intervention within the pediatric population. Existing research supports the efficacy of yoga for chronic pain management.

Granular cell tumors (GCTs) are rare neoplasms of neuroectodermal origin characterized by large polygonal cells with abundant eosinophilic and granular cytoplasm. GCTs rarely affect the lungs, with only a few cases reported in the literature. The pathophysiology of this Schwann cell-derived condition is not well understood but is thought to be due to recurring genetic mutations. GCTs have been linked with Noonan syndrome. Here, we report the case of a 17-year-old caucasian male who presented with partial upper airway obstruction due to a GCT. This case promotes awareness among pathologists and clinicians for this condition in the workup of patients presenting with upper airway obstruction.

Rasmussen's encephalitis is a rare neurological disease first described in 1958 that is characterized by medico-refractory seizures, focal unilateral cerebral inflammation, and deficits such as hemiparesis. While we still do not have a full understanding of this disease, proposed theories behind its etiology include auto-immune manifestations, immune attack by T cells, and malfunctional alterations in genetic expression. It is classically considered a rare childhood malady with a median age of onset of six years, and cases in adolescents and adults are even rarer, representing up to 10% of all cases to date. In this report, we would like to share a rare case of Rasmussen's encephalitis that occurred in an adolescent. Our 17-year-old male patient presented with signs and symptoms beginning at age 14 and was initially diagnosed with cerebral palsy only to later present with additional symptoms and characteristic EEG and MRI findings that ultimately led to a diagnosis of Rasmussen's encephalitis. Thus, with this case report, our intent is twofold: to shed light on an atypical presentation of an already rare disease, even rarer in adolescents and adults, and to underscore the importance of keeping a broad differential when it comes to evaluating a patient with seizures.

BACKGROUND AND OBJECTIVES: Research on in utero opioid exposure impacts has focused on Neonatal Opioid Withdrawal Syndrome (NOWS). However, possible impacts on fetal growth and newborn wellbeing have emerged, with inconsistencies likely driven by methodological issues. Our goal was to compare birth outcomes between newborns with prenatal opioid exposure and a matched control group. METHODS: Participants were identified manual review of electronic medical records of all deliveries over five years within a regional health system (6 delivery hospitals across 2 states). From over 18,000 births, 300 with prenatal opioid exposure and 300 control newborns matched on exposure, medical, and background factors were included. Additional factors were statistically controlled. Outcomes included pregnancy/delivery complications, newborn size, and newborn health complications. RESULTS: Compared to biochemically verified controls, exposed newborns had higher rates of fetal growth restriction, weighed less, had decreased length and head circumference, and had higher rates of respiratory distress, sepsis, and jaundice. No significant differences in gestational length, Apgar scores, or neonatal hypoglycemia were found. Adjusted regression analyses revealed that compared to controls, those exposed had an average 150 g decrease in birth weight, a two-fold increased risk for IUGR (OR = 2.09), a nearly three-fold (OR = 2.80) increased risk for jaundice, a more than seven-fold (OR = 7.40) increased risk for respiratory distress, and a thirty-fold (OR = 30.47) increased risk for sepsis. CONCLUSIONS: Results suggest significant pregnancy and newborn outcomes beyond NOWS following pregnancy opioid use, informing clinical screening and treatment decisions to enhance health and wellbeing in pregnancy, during the neonatal period, and beyond.

Background and objectives: Research on in utero opioid exposure impacts has focused on Neonatal Opioid Withdrawal Syndrome (NOWS). However, possible impacts on fetal growth and newborn wellbeing have emerged, with inconsistencies likely driven by methodological issues. Our goal was to compare birth outcomes between newborns with prenatal opioid exposure and a matched control group. Methods: Participants were identified via manual review of electronic medical records of all deliveries over five years within a regional health system (6 delivery hospitals across 2 states). From over 18,000 births, 300 with prenatal opioid exposure and 300 control newborns matched on exposure, medical, and background factors were included. Additional factors were statistically controlled. Outcomes included pregnancy/delivery complications, newborn size, and newborn health complications. Results: Compared to biochemically verified controls, exposed newborns had higher rates of fetal growth restriction, weighed less, had decreased length and head circumference, and had higher rates of respiratory distress, sepsis, and jaundice. No significant differences in gestational length, Apgar scores, or neonatal hypoglycemia were found. Adjusted regression analyses revealed that compared to controls, those exposed had an average 150 g decrease in birth weight, a two-fold increased risk for IUGR (OR = 2.09), a nearly three-fold (OR = 2.80) increased risk for jaundice, a more than seven-fold (OR = 7.40) increased risk for respiratory distress, and a thirty-fold (OR = 30.47) increased risk for sepsis. Conclusions: Results suggest significant pregnancy and newborn outcomes beyond NOWS following pregnancy opioid use, informing clinical screening and treatment decisions to enhance health and wellbeing in pregnancy, during the neonatal period, and beyond.

Effective communication with the parents of pediatric clients is considered an essential skill and encompasses the verbal exchanging of ideas, listening, and non-verbal communication (Taylor, 2020). Similarly, the therapeutic use of self is integral to the practice of occupational therapy and consists of the conscious enhancement of communication through the use of planned strategies for intentional client-therapist interactions (Taylor, 2020). However, many occupational therapy practitioners report communication challenges, such as parent emotional expressions (Andrews et al., 2013) and discussing parent roles and expectations (Kruijsen-Terpstra et al., 2016 ), and implementing the therapeutic use of self in practice (Bonsaksen et al., 2013). Furthermore, factors such as the limited availability of communication skills training, a limited understanding of how to practice reflection to enhance communication self-awareness (King et al., 2017), and decreased self-efficacy (Coad et al., 2018) hinder the opportunity for practitioners to enhance their communication competencies. The following chapters discuss the evidence base and guiding theories informing the development of the proposed program, Communicate to Collaborate. Communicate to Collaborate is a communication skills training that aims to strengthen pediatric therapy practitioners’ interpersonal communication skills so that how they communicate with families becomes an active, mediating ingredient in their therapy interventions. Through program participation, it is anticipated practitioners will gain greater awareness of both their personal communication approaches and parent’s communication preferences and increased self-efficacy in how to communicate intentionally with parents, thus enhancing their therapeutic use of self in practice and improving the quality of family-centered pediatric therapy services.

No description available.